← Back to Search

ePRIDE for Human Immunodeficiency Virus Infection

Phase 1
Waitlist Available
Led By Colleen Hoff, PhD
Research Sponsored by San Francisco State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months (baseline, 3, 6, and 9 month followups)
Awards & highlights

Study Summary

This trial will test whether two different interventions can reduce sexual risk for HIV among gay couples.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months (baseline, 3, 6, and 9 month followups)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months (baseline, 3, 6, and 9 month followups) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite Risk for HIV (CR-HIV)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ePRIDEExperimental Treatment1 Intervention
ePRIDE is an online adaptation of the experimental condition, PRIDE, and consists of online intervention activities that are scheduled to be completed over two weeks, lasting approximately 6 hours total. This intervention consists of relationship-focused activities for couples to take part in together, focusing on relationship communication, dynamics, and sexual agreements, and is designed for couples to take together sitting side by side.
Group II: PRIDEExperimental Treatment1 Intervention
The in-person experimental condition, PRIDE, consists of in-person intervention activities that are scheduled over two Saturdays, back to back, approximately 3 hours each (6 hours total). This intervention consists of relationship-focused activities for couples to take part in together, focusing on relationship communication, dynamics, and sexual agreements.
Group III: Men's HealthActive Control1 Intervention
Men's Health is the active comparator group. Participants in this group go through in-person intervention days, scheduled on Saturdays back to back, but differ from the PRIDE arm because this intervention does not focus on relationship dynamics. Instead, these two Saturday intervention days focus on general men's health, including heart health, cancer, and STDs.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityOTHER
2,250 Previous Clinical Trials
14,817,004 Total Patients Enrolled
San Francisco State UniversityLead Sponsor
11 Previous Clinical Trials
1,857 Total Patients Enrolled
University of California, San FranciscoOTHER
2,498 Previous Clinical Trials
11,935,748 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Randomized Trial to Prevent HIV Among Gay Couples
2017. "A Randomized Trial to Prevent HIV Among Gay Couples". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03189394.
~77 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top